This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase Ib/II, open-label study of LJM716 in combi...
Clinical trial

A phase Ib/II, open-label study of LJM716 in combination with BYL719 compared to taxane or irinotecan in patients with previously treated esophageal squamous cell carcinoma

Read time: 1 mins
Last updated:6th Jun 2013
To study the safety and efficacy of the combination of LJM716 and BYL719 against currently available treatments of physician�s choice in previously treated ESCC patients
Category Value
Study start date 2013-06-06

View full details